|
1
|
González-Quezada BA, Santana-Bejarano UF,
Corona-Rivera A, Pimentel-Gutiérrez HJ, Silva-Cruz R,
Ortega-De-la-Torre C, Franco-Topete R, Franco-Topete K,
Centeno-Flores MW, Maciel-Gutiérrez VM, et al: Expression profile
of NF-κB regulated genes in sporadic colorectal cancer patients.
Oncol Lett. 15:7344–7354. 2018.
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2019. CA Cancer J Clin. 69:7–34. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chiu HM, Hsu WF, Chang LC and Wu MH:
Colorectal cancer screening in Asia. Curr Gastroenterol Rep.
19:472017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Abraha I, Aristei C, Palumbo I, Lupattelli
M, Trastulli S, Cirocchi R, De Florio R and Valentini V:
Preoperative radiotherapy and curative surgery for the management
of localised rectal carcinoma. Cochrane Database Syst Rev.
10:Cd0021022018.PubMed/NCBI
|
|
5
|
Liu N, Cui W, Jiang X, Zhang Z, Gnosa S,
Ali Z, Jensen L, Jönsson JI, Blockhuys S, Lam EWF, et al: The
critical role of dysregulated RhoB signaling pathway in
radioresistance of colorectal cancer. Int J Radiat Oncol Biol Phys.
104:1153–1164. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Alsamman K and El-Masry OS: Interferon
regulatory factor 1 inactivation in human cancer. Biosci Rep.
38:BSR201716722018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Campos Carrascosa L, Klein M, Kitagawa Y,
Lückel C, Marini F, König A, Guralnik A, Raifer H, Hagner-Benes S,
Rädler D, et al: Reciprocal regulation of the Il9 locus by
counteracting activities of transcription factors IRF1 and IRF4.
Nat Commun. 8:153662017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Carrascosa LC, Klein M, Kitagawa Y, Lückel
C, Marini F, König A, Guralnik A, Raifer H, Hagner-Benes S, Rädler
D, et al: Reciprocal regulation of the Il9 locus by counteracting
activities of transcription factors IRF1 and IRF4. Nat Commun.
8:153662017. View Article : Google Scholar
|
|
9
|
Ramsauer K, Farlik M, Zupkovitz G, Seiser
C, Kröger A, Hauser H and Decker T: Distinct modes of action
applied by transcription factors STAT1 and IRF1 to initiate
transcription of the IFN-gamma-inducible gbp2 gene. Proc Natl Acad
Sci USA. 104:2849–2854. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cook KL, Schwartz-Roberts JL, Baumann WT
and Clarke R: Linking autophagy with inflammation through IRF1
signaling in ER+ breast cancer. Mol Cell Oncol. 3:e10239282015.
View Article : Google Scholar
|
|
11
|
Walch-Ruckheim B, Pahne-Zeppenfeld J,
Fischbach J, Wickenhauser C, Horn LC, Tharun L, Büttner R, Mallmann
P, Stern P, Kim YJ, et al: STAT3/IRF1 pathway activation sensitizes
cervical cancer cells to chemotherapeutic drugs. Cancer Res.
76:3872–3883. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mao L, Zhang Y, Mo W, Yu Y and Lu H: BANF1
is downregulated by IRF1-regulated microRNA-203 in cervical cancer.
PLoS One. 10:e01170352015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yu M, Xue H, Wang Y, Shen Q, Jiang Q,
Zhang X, Li K, Jia M, Jia J, Xu J and Tian Y: miR-345 inhibits
tumor metastasis and EMT by targeting IRF1-mediated mTOR/STAT3/AKT
pathway in hepatocellular carcinoma. Int J Oncol. 50:975–983. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ebine K, Kumar K, Pham TN, Shields MA,
Collier KA, Shang M, DeCant BT, Urrutia R, Hwang RF, Grimaldo S, et
al: Interplay between interferon regulatory factor 1 and BRD4 in
the regulation of PD-L1 in pancreatic stellate cells. Sci Rep.
8:132252018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kanayama M, Hayano T, Koebis M, Maeda T,
Tabe Y, Horie S and Aiba A: Hyperactive mTOR induces neuroendocrine
differentiation in prostate cancer cell with concurrent
up-regulation of IRF1. Prostate. 77:1489–1498. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bachmann SB, Frommel SC, Camicia R,
Winkler HC, Santoro R and Hassa PO: DTX3L and ARTD9 inhibit IRF1
expression and mediate in cooperation with ARTD8 survival and
proliferation of metastatic prostate cancer cells. Mol Cancer.
13:1252014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yuan L, Zhou C, Lu Y, Hong M, Zhang Z,
Zhang Z, Chang Y, Zhang C and Li X: IFN-γ-mediated IRF1/miR-29b
feedback loop suppresses colorectal cancer cell growth and
metastasis by repressing IGF1. Cancer Lett. 359:136–147. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hong M, Zhang Z, Chen Q, Lu Y, Zhang J,
Lin C, Zhang F, Zhang W and Li X, Zhang W and Li X: IRF1 inhibits
the proliferation and metastasis of colorectal cancer by
suppressing the RAS-RAC1 pathway. Cancer Manag Res. 11:369–378.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen X, Liu L, Mims J, Punska EC, Williams
KE, Zhao W, Arcaro KF, Tsang AW, Zhou X and Furdui CM: Analysis of
DNA methylation and gene expression in radiation-resistant head and
neck tumors. Epigenetics. 10:545–561. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen J, Markelc B, Kaeppler J, Ogundipe
VML, Cao Y, McKenna WG and Muschel RJ: STING-dependent
interferon-λ1 induction in HT29 cells, a human colorectal cancer
cell line, after gamma-radiation. Int J Radiat Oncol Biol Phys.
101:97–106. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gonzalez RS, Raza A, Propst R, Adeyi O,
Bateman J, Sopha SC, Shaw J and Auerbach A: Recent advances in
digestive tract tumors: Updates from the 5th edition of the world
health organization 'Blue Book'. Arch Pathol Lab Med. Jul
31–2020.Epub ahead of print. View Article : Google Scholar
|
|
22
|
Xu X, Song C, Chen Z, Yu C, Wang Y, Tang Y
and Luo J: Downregulation of HuR inhibits the progression of
esophageal cancer through interleukin-18. Cancer Res Treat.
50:71–87. 2018. View Article : Google Scholar :
|
|
23
|
Thul PJ and Lindskog C: The human protein
atlas: A spatial map of the human proteome. Protein Sci.
27:233–244. 2018. View Article : Google Scholar
|
|
24
|
Yang XD, Xu XH, Zhang SY, Wu Y, Xing CG,
Ru G, Xu HT and Cao JP: Role of miR-100 in the radioresistance of
colorectal cancer cells. Am J Cancer Res. 5:545–559.
2015.PubMed/NCBI
|
|
25
|
Kim D, Langmead B and Salzberg SL: HISAT:
A fast spliced aligner with low memory requirements. Nat Methods.
12:357–360. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Roberts A, Trapnell C, Donaghey J, Rinn JL
and Pachter L: Improving RNA-Seq expression estimates by correcting
for fragment bias. Genome Biol. 12:R222011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Trapnell C, Williams BA, Pertea G,
Mortazavi A, Kwan G, van Baren MJ, Salzberg SL, Wold BJ and Pachter
L: Transcript assembly and quantification by RNA-Seq reveals
unannotated transcripts and isoform switching during cell
differentiation. Nat Biotechnol. 28:511–515. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Anders S, Pyl PT and Huber W: HTSeq-a
Python framework to work with high-throughput sequencing data.
Bioinformatics. 31:166–169. 2015. View Article : Google Scholar
|
|
29
|
Anders S and Huber W: Differential
expression of RNA-Seq data at the gene level - the DESeq package.
European Molecular Biology Laboratory (EMBL); Germany:
|
|
30
|
Zheng Q and Wang XJ: GOEAST: A web-based
software toolkit for gene ontology enrichment analysis. Nucleic
Acids Res. 36:W358–W363. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kanehisa M, Araki M, Goto S, Hattori M,
Hirakawa M, Itoh M, Katayama T, Kawashima S, Okuda S, Tokimatsu T
and Yamanishi Y: KEGG for linking genomes to life and the
environment. Nucleic Acids Res. 36:D480–D484. 2008. View Article : Google Scholar :
|
|
32
|
Xie Y, Zhu S, Song X, Sun X, Fan Y, Liu J,
Zhong M, Yuan H, Zhang L, Billiar TR, et al: The tumor suppressor
p53 limits ferroptosis by blocking DPP4 activity. Cell Rep.
20:1692–1704. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tauriello DVF, Palomo-Ponce S, Stork D,
Berenguer-Llergo A, Badia-Ramentol J, Iglesias M, Sevillano M,
Ibiza S, Cañellas A, Hernando-Momblona X, et al: TGFβ drives immune
evasion in genetically reconstituted colon cancer metastasis.
Nature. 554:538–543. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kim BM and Hong Y, Lee S, Liu P, Lim JH,
Lee YH, Lee TH, Chang KT and Hong Y: Therapeutic implications for
overcoming radiation resistance in cancer therapy. Int J Mol Sci.
16:26880–26913. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Gao Z, Li Y, Wang F, Huang T, Fan K, Zhang
Y, Zhong J, Cao Q, Chao T, Jia J, et al: Mitochondrial dynamics
controls anti-tumour innate immunity by regulating CHIP-IRF1 axis
stability. Nat Commun. 8:18052017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Cascone T, McKenzie JA, Mbofung RM, Punt
S, Wang Z, Xu C, Williams LJ, Wang Z, Bristow CA, Carugo A, et al:
Increased tumor glycolysis characterizes immune resistance to
adoptive T cell therapy. Cell Metab. 27:977–987.e974. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Xiong W, Deng H, Huang C, Zen C, Jian C,
Ye K, Zhong Z, Zhao X and Zhu L: MLL3 enhances the transcription of
PD-L1 and regulates anti-tumor immunity. Biochim Biophys Acta Mol
Basis Dis. 1865:454–463. 2019. View Article : Google Scholar
|
|
38
|
Lu C, Redd PS, Lee JR, Savage N and Liu K:
The expression profiles and regulation of PD-L1 in tumor-induced
myeloid-derived suppressor cells. Oncoimmunology. 5:e12471352016.
View Article : Google Scholar
|
|
39
|
Garcia-Diaz A, Shin DS, Moreno BH, Saco J,
Escuin-Ordinas H, Rodriguez GA, Zaretsky JM, Sun L, Hugo W, Wang X,
et al: Interferon receptor signaling pathways regulating PD-L1 and
PD-L2 expression. Cell Rep. 29:37662019. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Shao L, Hou W, Scharping NE, Vendetti FP,
Srivastava R, Roy CN, Menk AV, Wang Y, Chauvin JM, Karukonda P, et
al: IRF1 inhibits antitumor immunity through the upregulation of
PD-L1 in the tumor cell. Cancer Immunol Res. 7:1258–1266. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Yang MQ, Du Q, Varley PR, Goswami J, Liang
Z, Wang R, Li H, Stolz DB and Geller DA: Interferon regulatory
factor 1 priming of tumour-derived exosomes enhances the antitumour
immune response. Br J Cancer. 118:62–71. 2018. View Article : Google Scholar :
|
|
42
|
Lai Q, Wang H, Li A, Xu Y, Tang L, Chen Q,
Zhang C, Gao Y, Song J and Du Z: Decitibine improve the efficiency
of anti-PD-1 therapy via activating the response to IFN/PD-L1
signal of lung cancer cells. Oncogene. 37:2302–2312. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Wu A, Wu Q, Deng Y, Liu Y, Lu J, Liu L, Li
X, Liao C, Zhao B and Song H: Loss of VGLL4 suppresses tumor PD-L1
expression and immune evasion. EMBO J. 38:e995062019. View Article : Google Scholar
|
|
44
|
Eschrich S, Zhang H, Zhao H, Boulware D,
Lee JH, Bloom G and Torres-Roca JF: Systems biology modeling of the
radiation sensitivity network: A biomarker discovery platform. Int
J Radiat Oncol Biol Phys. 75:497–505. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Ohsugi T, Yamaguchi K, Zhu C, Ikenoue T,
Takane K, Shinozaki M, Tsurita G, Yano H and Furukawa Y:
Anti-apoptotic effect by the suppression of IRF1 as a downstream of
Wnt/β-catenin signaling in colorectal cancer cells. Oncogene.
38:6031–6064. 2019. View Article : Google Scholar
|
|
46
|
Wan P, Zhang J, Du Q and Geller DA: The
clinical significance and biological function of interferon
regulatory factor 1 in cholangiocarcinoma. Biomed Pharmacother.
97:771–777. 2018. View Article : Google Scholar
|
|
47
|
Qi L, Li T, Shi G, Wang J, Li X, Zhang S,
Chen L, Qin Y, Gu Y, Zhao W and Guo Z: An individualized gene
expression signature for prediction of lung adenocarcinoma
metastases. Mol Oncol. 11:1630–1645. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Zhou Y, Wang Q, Chu L, Dai W, Zhang X,
Chen J, Zhang L, Ding P, Zhang X, Gu H, et al: FOXM1c promotes
oesophageal cancer metastasis by transcriptionally regulating IRF1
expression. Cell Prolif. 52:e125532019. View Article : Google Scholar
|
|
49
|
Jiang L, Liu JY, Shi Y, Tang B, He T, Liu
JJ, Fan JY, Wu B, Xu XH, Zhao YL, et al: MTMR2 promotes invasion
and metastasis of gastric cancer via inactivating IFNγ/STAT1
signaling. J Exp Clin Cancer Res. 38:2062019. View Article : Google Scholar
|
|
50
|
Meyer K, Kwon YC, Liu S, Hagedorn CH, Ray
RB and Ray R: Interferon-α inducible protein 6 impairs EGFR
activation by CD81 and inhibits hepatitis C virus infection. Sci
Rep. 5:90122015. View Article : Google Scholar
|
|
51
|
Wu X, Wang S, Yu Y, Zhang J, Sun Z, Yan Y
and Zhou J: Subcellular proteomic analysis of human host cells
infected with H3N2 swine influenza virus. Proteomics. 13:3309–3326.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Hussein HA, Briestenska K, Mistrikova J
and Akula SM: IFITM1 expression is crucial to gammaherpesvirus
infection, in vivo. Sci Rep. 8:141052018. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Cheriyath V, Kaur J, Davenport A, Khalel
A, Chowdhury N and Gaddipati L: G1P3 (IFI6), a mitochondrial
localised antiapoptotic protein, promotes metastatic potential of
breast cancer cells through mtROS. Br J Cancer. 119:52–64. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Lui AJ, Geanes ES, Ogony J, Behbod F,
Marquess J, Valdez K, Jewell W, Tawfik O and Lewis-Wambi J: IFITM1
suppression blocks proliferation and invasion of aromatase
inhibitor-resistant breast cancer in vivo by JAK/STAT-mediated
induction of p21. Cancer Lett. 399:29–43. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Shirai K, Shimada T, Yoshida H, Hayakari
R, Matsumiya T, Tanji K, Murakami M, Tanaka H and Imaizumi T:
Interferon (IFN)-induced protein 35 (IFI35) negatively regulates
IFN-β-phosphorylated STAT1-RIG-I-CXCL10/CCL5 axis in U373MG
astrocytoma cells treated with polyinosinic-polycytidylic acid.
Brain Res. 1658:60–67. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Jung JJ, Jeung HC, Chung HC, Lee JO, Kim
TS, Kim YT, Noh SH and Rha SY: In vitro pharmacogenomic database
and chemosensitivity predictive genes in gastric cancer. Genomics.
93:52–61. 2009. View Article : Google Scholar
|
|
57
|
Gómez-Herranz M, Nekulova M, Faktor J,
Hernychova L, Kote S, Sinclair EH, Nenutil R, Vojtesek B, Ball KL
and Hupp TR: The effects of IFITM1 and IFITM3 gene deletion on IFNg
stimulated protein synthesis. Cell Signall. 60:39–56. 2019.
View Article : Google Scholar
|
|
58
|
Yang W, Tan J, Liu R, Cui X, Ma Q, Geng Y
and Qiao W: Interferon-g upregulates expression of IFP35 gene in
HeLa cells via interferon regulatory factor-1. PLoS One.
7:e509322012. View Article : Google Scholar
|
